Inventor · disambiguated record
Juan Jose Marugan
Also filed as: MARUGAN JUAN J · MARUGAN JUAN JOSE · MARUGAN Juan
30 granted patents·16 pending applications·156 citations·filing 1999–2025
95Inventor score
Files withUS HEALTH15DIMENSIONAL PHARM INC3MASSACHUSETTS GEN HOSPITAL3THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES3MARUGAN JUAN JOSE2
Top patents by PatentIndex Score
46 records- 0196US9044451B2Use of delta tocopherol for the treatment of lysosomal storage disordersZHENG WEI·Filed 2011·Granted Jun 2, 2015·36 cites·18 claims
- 0290US9353117B2Substituted pyrazolopyrimidines as glucocerebrosidase activatorsMARUGAN JUAN JOSE·Filed 2011·Granted May 31, 2016·25 cites·26 claims
- 0390US6403633B2Heteroaryl amidines, methylamidines and guanidines, and use thereof as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2001·Granted Jun 11, 2002·21 cites·108 claims
- 0487US6562840B1Heteroaryl amidines, methylamidines and guanidines, and the use thereof as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2002·Granted May 13, 2003·16 cites·36 claims
- 0585US9550742B211-OXO-10,11-dihydrodibenzo[B,F][1,4]thiazepine S-oxide derivatives and their use as dopamine D2 receptor antagonistsTHE US SECRETARY DEPT OF HEALTH AND HUMAN·Filed 2014·Granted Jan 24, 2017·21 cites·22 claims
- 0683US11253511B2Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)UNIV JOHNS HOPKINS·Filed 2017·Granted Feb 22, 2022·2 cites·4 claims
- 0780US10676475B2Compounds for improving mRNA splicingMASSACHUSETTS GEN HOSPITAL·Filed 2016·Granted Jun 9, 2020·2 cites·5 claims
- 0879US11471460B2Autophagy modulators for use in treating cancerUS HEALTH·Filed 2020·Granted Oct 18, 2022·1 cites·8 claims
- 0978US11020422B2Cyclodextrin for the treatment of lysosomal storage diseasesUS HEALTH·Filed 2017·Granted Jun 1, 2021·1 cites·6 claims
- 1078US9663485B2Tocopherol and tocopheryl quinone derivatives as correctors of Lysosomal Storage DisordersUS HEALTH·Filed 2013·Granted May 30, 2017·3 cites·17 claims
- 1177US9663521B2Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenesisUS HEALTH·Filed 2012·Granted May 30, 2017·3 cites·19 claims
- 1277US9446048B2Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteinsLIU PU·Filed 2012·Granted Sep 20, 2016·4 cites·13 claims
- 1377US2024316056A1Formulations and methods for the prevention and treatment of tumor metastasis and tumorigenesisUS HEALTH·Filed 2024·Application pending·0 cites
- 1476US2025340521A1C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the sameTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2025·Application pending·0 cites
- 1575US9974789B2Substituted pyrazolopyrimidines as glucocerebrosidase activatorsTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN·Filed 2016·Granted May 22, 2018·2 cites·20 claims
- 1675US6291514B1Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitorsDIMENSIONAL PHARM INC·Filed 1999·Granted Sep 18, 2001·15 cites·60 claims
- 1774US2023279007A1Compounds for Improving mRNA SplicingMASSACHUSETTS GEN HOSPITAL·Filed 2023·Application pending·0 cites
- 1873US12435047B2c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the sameTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2023·Granted Oct 7, 2025·0 cites·19 claims
- 1972US10301314B2Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenesisUS HEALTH·Filed 2017·Granted May 28, 2019·1 cites·9 claims
- 2071US9452973B2Modulators of the relaxin receptor 1THE US SECRETARY DEPT OF HEALTH AND HUMAN SERVICE·Filed 2013·Granted Sep 27, 2016·1 cites·18 claims
- 2170US12208093B2Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)UNIV JOHNS HOPKINS·Filed 2022·Granted Jan 28, 2025·0 cites·4 claims
- 2267US11702417B2Compounds for improving mRNA splicingMASSACHUSETTS GEN HOSPITAL·Filed 2020·Granted Jul 18, 2023·0 cites·13 claims
- 2365US11241436B2Autophagy inducers for treatment of CNS conditionsUNIV NORTHWESTERN·Filed 2018·Granted Feb 8, 2022·1 cites·9 claims
- 2464US9464035B2Salicylic acid derivatives useful as glucocerebrosidase activatorsUS HEALTH·Filed 2013·Granted Oct 11, 2016·1 cites·11 claims
- 2562US10925874B2Substituted pyrazolopyrimidines as glucocerebrosidase activatorsTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICE·Filed 2018·Granted Feb 23, 2021·0 cites·18 claims
- 2659US2021186972A1Formulations and methods for the prevention and treatment of tumor metastasis and tumorigenesisTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2019·Application pending·0 cites
- 2759US2025134907A1Fused diazepines as agonists of the insulin-like 3 (insl3) peptide receptor rxfp2 and methods of use thereofUS HEALTH·Filed 2023·Application pending·0 cites
- 2858US11649218B2C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the sameTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2019·Granted May 16, 2023·0 cites·18 claims
- 2957US9422308B2Derivatives of docosahexaenoylethanolamide and uses thereofUS HEALTH·Filed 2013·Granted Aug 23, 2016·0 cites·22 claims
- 3057US2024391928A1Compositions for the treatment of food and chemical addiction and methods of making and using sameUNIV DUKE·Filed 2022·Application pending·0 cites
- 3156US10039741B2Use of delta tocopherol for the treatment of lysosomal storage disordersTHE US SECRETARY DEPT OF HEALTH & HUMAN SERVICES·Filed 2016·Granted Aug 7, 2018·0 cites·20 claims
- 3255US2015265571A1Use of delta tocopherol for the treatment of lysosomal storage disordersUS HEALTH·Filed 2015·Application pending·0 cites
- 3354US10370348B2Tocopherol and tocopheryl quinone derivatives as correctors of lysosomal storage disordersUS HEALTH·Filed 2017·Granted Aug 6, 2019·0 cites·1 claims
- 3453US10125112B2Modulators of the relaxin receptor 1THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICE·Filed 2016·Granted Nov 13, 2018·0 cites·3 claims
- 3553US2024002350A1Protein and lipid therapeutic targetsUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2021·Application pending·0 cites
- 3652US2022315548A1Small molecule agonists of mucolipin 1 and uses thereofUNIV MICHIGAN REGENTS·Filed 2020·Application pending·0 cites
- 3749US9173898B2Methods of treating giardiasisZHENG WEI·Filed 2011·Granted Nov 3, 2015·0 cites·1 claims
- 3848US2023158025A1Galactokinase inhibitorsLUI LI·Filed 2021·Application pending·0 cites
- 3947US2015216895A1Cyclodextrin for the treatment of lysosomal storage diseasesUS HEALTH·Filed 2013·Application pending·0 cites
- 4044US2023056497A1CD206 Modulators Their Use and Methods for PreparationUS HEALTH·Filed 2020·Application pending·0 cites
- 4144US2014155420A1Inhibitors of eya2ZHAO RUI·Filed 2012·Application pending·0 cites
- 4242US2017001988A1Piperidine and piperazine derivatives and their use in treating viral infections and cancerUS HEALTH·Filed 2014·Application pending·0 cites
- 4334US2013096160A1Arylthiazolyl piperidines and related compounds as modulators of survival motor neuron (smn) protein productionMARUGAN JUAN JOSE·Filed 2011·Application pending·0 cites
- 4434US2013004490A1Delivery of transthyretin across the blood-brain barrier as a treatment for alzheimer's diseaseUS OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT·Filed 2010·Application pending·0 cites
- 4532US10202367B2Heterocyclic compounds and methods of use thereofUS HEALTH·Filed 2015·Granted Feb 12, 2019·0 cites·6 claims
- 4631US10239830B2Benzenesulfonamide upregulators of NPC1 for Neimann-Pick disease and other lysosomal storage disordersICAHN SCHOOL MED MOUNT SINAI·Filed 2016·Granted Mar 26, 2019·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when Juan Jose Marugan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →